Salone Sehgal On The Neuroscience Of Engagement With Outlook Respawn (Part 2 of 3)

Engagement, retention and monetisation make up the holy trinity of any digital product, and the platforms that master all three tend to share the same chemistry.

In Part 2 of the Outlook Respawn x Lumikai series, Salone Sehgal, Founder and Managing Partner of Lumikai, unpacks the neuroscience behind that trinity and what it takes to build the next wave of breakout digital platforms.

She decodes Lumikai's DOSE framework, the four neurochemical drivers of Dopamine, Oxytocin, Serotonin and Endorphins at the heart of every successful consumer app. From virtual gifting to subscriptions, she shows that Indian consumers pay once the right rails are in place, and explains why Lumikai backs founders with 24-month runways and how 85% of its seed portfolio is already revenue-generating.

If you're designing a product people come back to, and pay for, this one gets under the hood.

Press play for a healthy dose of insight.